Amalgamated Financial’s Elevance Health ELV Stock Holding History

Amalgamated Financial’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$32M	Buy	+65,098	New	+$29.8M	0.25%	62

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Amalgamated Financial's ELV Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Elevance Health (ELV) in Q1 2022: 65,098 shares worth $32M. The stake represents 0.25% of the portfolio and ranks #62 among its holdings.

1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

Amalgamated Financial held 65,098 shares of Elevance Health worth $32M as of Q1 2022.
Elevance Health was a new Amalgamated Financial position in Q1 2022.
Elevance Health made up 0.25% of Amalgamated Financial's portfolio in Q1 2022, its #62 holding.
1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.